SEC 2026 Concludes Successfully | The Grand Gathering in the Star City Comes to a Close, Embarking on a New Journey in Vascular Diagnosis and Treatment
On July 19, 2026, EndoVas Medical participated in the 19th China Southern Vascular Conference (SEC 2026) and the 15th Xiangya Vascular Forum. At the exhibition, EndoVas Medical made a prominent appearance with its two core venous interventional products: the V-SAILING® Peripheral Thrombectomy System and the V-Mixtent® Venous Stent System were both fully displayed. Together with vascular surgery experts and colleagues from across the country, the company gathered by the banks of the Xiangjiang River, jointly delivering a benchmark academic exchange feast in the field of vascular diseases in China.
switchboard：+86 21 33658866
Scan to follow the official account
